Suven Life Sciences Ltd.

₹261.35

-6.8 (-2.6%)

SUVEN Share Price

HEALTHCARE SERVICES

As on October 23, 2026

SectorHealthcare

IndustryHEALTHCARE SERVICES

Basic IndustryHealthcare Research Analytics & Technology

Market Cap₹ 7,397.49 Cr

P/E Ratio-24.94

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	280.36	Bearish
10-DMA	284.01	Bearish
20-DMA	299.75	Bearish
50-DMA	333.63	Bearish
100-DMA	316.63	Bearish
200-DMA	245.63	Bullish

Historical Performance

1 Year

34.8%

3 Years

299%

5 Years

155.7%

10 Years

42.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	71	67	117	135	118
Total Expenditure	2,915	1,723	1,396	1,393	1,341
Other Income	139	109	211	84	16
Operating Profit	-2,704	-1,548	-1,067	-1,173	-1,206
Interest	3	2	3	4	7
Depreciation	56	58	65	65	44
Profit Before Tax	-2,763	-1,607	-1,061	-1,183	-1,220
Consolidated Net Profit	-2,763	-1,607	-1,051	-1,183	-1,220
Adjusted EPS	-10	-7	-5	-5	-8

Compounded Sales Growth

10 Years:-57.3

5 Years:-12

3 Years:-12.1

TTM:1.3

Compounded Profit Growth

10 Years:5.9

5 Years:30.8

3 Years:18.5

TTM:11.4

Stock Price CAGR

10 Years:3.6

5 Years:20.7

3 Years:58.6

TTM:30.9

Return on Equity

10 Years:6.3

5 Years:-7.7

3 Years:-4.8

last year:-10.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	264	218	218	218	145
Total Reserves	4,078	869	2,482	3,535	816
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	141	17	13	25	36
Other Current Liabilities	124	166	103	84	54
Short Term Borrowings	---	---	---	---	---
Total Liabilities	6,242	1,352	2,849	4,828	2,019
Capital Work in Progress	36	---	---	---	36
Long Term Loans & Advances	9	---	---	1	3
Currents Investments	1,807	223	759	463	452
Short Term Loans and Advances	223	128	120	1,089	1,073
Total Current Assets	5,467	755	2,567	3,455	1,605
Total Assets	6,242	1,352	2,849	4,828	2,019
Adjusted Book Value	16	5	12	17	6

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -24.94, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 59.9%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-2704 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹71 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1308975.3

No. of Shares: 5009 (Approx)

Performance:30.9%

308975.3

NIFTY Performance: -12.4%

1 day Top Gainers